Advik Laboratories Ltd

NSE: ADVIKLA · BSE: 531686 · Pharmaceuticals & Biotechnology · 13 announcements

Share price: ₹2.08
Market cap: ₹3.98 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-1.02 Cr
P/E (TTM): -3.8×Sector 47.3×
Promoter holding: 35.89%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Financial Results 3 Board Meeting Date 3 Debt & Borrowing 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

19 Apr 2026 14:48 IST BSE

Debt & Borrowing

Advik Laboratories Debt & Borrowing

MPS Pharmaa Limited (formerly Advik Laboratories Limited) confirmed it does not fall under the 'Large Corporate' category as of March 31, 2026. This disclosure complies with SEBI's framework for fund raising via debt securities issuance. The company remains exempt from specific debt-sourcing requirements mandated for large corporate entities.

Read the filing ↗